The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.
- Published In:
- Progress in neurobiology, 125, 26-46 (2015)
- Authors:
- Wright, John W, Kawas, Leen H, Harding, Joseph W
- Database ID:
- RPEP-02837
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02837APA
Wright, John W; Kawas, Leen H; Harding, Joseph W. (2015). The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.. Progress in neurobiology, 125, 26-46. https://doi.org/10.1016/j.pneurobio.2014.11.004
MLA
Wright, John W, et al. "The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.." Progress in neurobiology, 2015. https://doi.org/10.1016/j.pneurobio.2014.11.004
RethinkPeptides
RethinkPeptides Research Database. "The development of small molecule angiotensin IV analogs to ..." RPEP-02837. Retrieved from https://rethinkpeptides.com/research/wright-2015-the-development-of-small
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.